Form 8-K - Current report:
SEC Accession No. 0001193125-22-311537
Filing Date
2022-12-23
Accepted
2022-12-23 07:00:34
Documents
19
Period of Report
2022-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d434336d8k.htm   iXBRL 8-K 47857
2 EX-3.1 d434336dex31.htm EX-3.1 64864
3 EX-5.1 d434336dex51.htm EX-5.1 11464
4 EX-10.1 d434336dex101.htm EX-10.1 192856
5 EX-10.2 d434336dex102.htm EX-10.2 15983
6 EX-99.1 d434336dex991.htm EX-99.1 10323
10 GRAPHIC g434336g1222043535463.jpg GRAPHIC 2213
11 GRAPHIC g434336g1222223908445.jpg GRAPHIC 3392
  Complete submission text file 0001193125-22-311537.txt   573248

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20221219.xsd EX-101.SCH 2872
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20221219_lab.xml EX-101.LAB 19503
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20221219_pre.xml EX-101.PRE 12171
13 EXTRACTED XBRL INSTANCE DOCUMENT d434336d8k_htm.xml XML 3710
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 221483346
SIC: 2834 Pharmaceutical Preparations